All Articles

Tesamorelin side effects are usually local and manageable. The bigger question is whether daily injections, glucose monitoring, and the HIV-lipodystrophy-approved label fit your actual needs.

TB-500's timing depends on one crucial distinction: the marketed fragment differs from the full thymosin beta-4 in human trials. Here's what the research shows—and why that separation changes everything for your protocol.

Pinealon dosage clarity starts with one decision: route first. The public evidence points to older oral-use patterns and newer mechanistic research—here's how to build real protocol confidence.

You can stop guessing at BPC-157 dosage. Real answers live in the current trials and published data—but route matters more than any single number. Here's the practical breakdown.

Epitalon dosing clarity comes from understanding what the real human routines show—short courses, route-specific protocols, and why one settled U.S. standard still doesn't exist.

The approved PT-141 injection (Vyleesi) delivers on-demand libido benefit with a real tradeoff: meaningful nausea, flushing, headache, and blood-pressure cautions. Know the clear safety profile before committing.

Argireline carries a strong safety record in topical skincare—the real question is formula fit and whether results match your expectations.

The AOD-9604 dosage question is clearest when you stick to clinical evidence: once-daily oral regimens in real human trials, followed by a larger study that changed everything. Here's what actually moved the needle.

Tirzepatide is the settled, approved option you can start using today. Retatrutide shows bigger weight-loss potential but remains investigational. Your pick depends on whether you want certainty now or the highest ceiling later.

Pinealon offers a genuinely different approach to cognition: restorative and neuroprotective, calmer than typical nootropics. The research is real and the mechanism is solid.

Master GHK-Cu dosage by treating topical and injectable as two different games. Topicals win on concentration and routine fit; injectables face tighter scrutiny. Route first, always.

Tesamorelin is a straightforward once-daily injection, but EGRIFTA WR and EGRIFTA SV use different strengths and mixing routines. The key insight: this is labeled for HIV-related abdominal fat, not general weight loss.